You searched for Humanized antibody - Page 14 of 44

Best in Biotech 20 Dec 2021

The Billion-Euro European Biotech Companies in 2022

…of antibody treatments for cancer and inflammatory and autoimmune diseases. Its first antibody, Tremfya, a treatment for psoriasis, was launched in 2017 in collaboration with Janssen. The company has ongoing…

December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 20 Jun 2023

Clearance for anti-tumor bispecific antibody trial

TG ImmunoPharma Co., Ltd. (TGI), which focuses on the development of novel immuno-oncology therapies, says the FDA has granted clearance for the clinical trial of TGI-6, its bispecific antibody. TGI-6…

June 20, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 13 Mar 2025

Nine biotechs thriving in Seattle in 2025

…interaction data at scale. This is done by characterizing protein-protein interaction networks with millions of interactions to aid in antibody and molecular glue target discovery and protein interface engineering. The…

March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter

News and Trends 15 Nov 2022

Biotheus enters agreement with Hansoh Pharma for bispecific antibody

…EGFR/MET bispecific antibody (also known as PM1080) in China, Hong Kong, Macao and Taiwan. Under the terms of the agreement, Hansoh will be granted by Biotheus the exclusive rights to…

November 15, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Oct 2016

And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!

…(ADCT) is a Swiss Biotech that develops antibody-drug conjugates (ADCs) for oncology applications. Its founder Auven Therapeutics and its partner AstraZeneca have participated in the biggest funding round of the…

October 19, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

Interview 5 Jun 2017

What Lies Ahead in Biotech for the UK’s Top Academic Entrepreneur?

…company, Cambridge Antibody Technology (CAT), would go on to be the biggest success story in UK biotech after its team discovered the blockbuster therapeutic antibody, Humira, and became part of…

June 5, 2017 - 7 minutesmins - By Evelyn Warner

antibody drug conjugate adc small cancer treatment

News and Trends 12 Jan 2023

Ajinomoto and Exelixis to discover and develop novel ADCs to treat cancer

…Ajinomoto Co.’s proprietary site-specific bioconjugation and stable linker technologies compatible with commonly used antibody isotypes. AJICAP technology includes its “off-the-shelf” feature, allowing any therapeutic antibody at any stage of development…

January 12, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 30 Jan 2017

The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge

…developed NGS technology now in the very powerful hands of Illumina; and the former Cambridge Antibody Technology, which developed the biggest biologicals blockbuster, Humira. As if all these companies weren’t…

January 30, 2017 - 8 minutesmins - By Denise Neves Gameiro

Interview 29 May 2017

Meet the Founder of the UK’s Best Biotech that Discovered Humira

…Antibody Technology (CAT), would go on to be the biggest success story in UK biotech after it discovered the blockbuster therapeutic antibody, Humira, and became part of AstraZeneca in 2006…

May 29, 2017 - 9 minutesmins - By Evelyn Warner

ADCs that deliver: The secret lies in rigorous characterization

Antibody-drug conjugates (ADCs) represent an innovative class of potent anti-cancer agents. They combine the specificity of a monoclonal antibody with the potency of a cytotoxic drug, enabling targeted killing of…

September 17, 2024 - 7 minutesmins - By Ute Boronowsky

News and Trends 20 Nov 2023

M&As: what’s up with the ADC buying spree?

Antibody drug conjugates (ADCs) have been much sought-after through investments of late, with big pharma eyeing these drugs developed by various biotechs, to eventually nab them. With yet another ADC…

November 20, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 1 Dec 2016

Spain joins the Antibody-Drug Conjugate Bandwagon to fight Cancer

…antibody-drug conjugate (ADC) candidate, MI130110, against fibrosarcoma and multiple myeloma. Which means the popular ADC field has managed to attract yet another company into what could be a major breakthrough…

December 1, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

The Billion-Euro European Biotech Companies in 2022

Clearance for anti-tumor bispecific antibody trial

Nine biotechs thriving in Seattle in 2025

Biotheus enters agreement with Hansoh Pharma for bispecific antibody

And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!

What Lies Ahead in Biotech for the UK’s Top Academic Entrepreneur?

Ajinomoto and Exelixis to discover and develop novel ADCs to treat cancer

The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge

Meet the Founder of the UK’s Best Biotech that Discovered Humira

ADCs that deliver: The secret lies in rigorous characterization

M&As: what’s up with the ADC buying spree?

Spain joins the Antibody-Drug Conjugate Bandwagon to fight Cancer

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!